GlycoScience Research receives Company of the Year award from Brookings Innovation Center

By: Melissa Werner, Research Park at SDSU

The Company of the Year Award was presented to GlycoScience Research on December 12th as part of the annual Innovation Celebration at the Brookings Innovation Center. Larry and Susan Holler with GlycoScience Research proudly accepted the award for creating an innovative product, promoting economic growth, and making a difference in the community.

“We’re honored to receive this award and are excited to be making progress toward clinical trials with GM1 ganglioside for Huntingtons’s Disease (HD).  Funding from The Bev Hartig Huntington’s Disease Foundation totaling $200,000 has allowed us to set up a lab at the Research Park and collaborate with scientists at the GEAR center in Sioux Falls. Additional funding has come through Sheep Industry grants and The Shepherd’s Gift: GM1 for HD, a non-profit founded by HD families.  The South Dakota Community Foundation has supported the Shepherd’s Gift and the community of cooperating sheep producers who are willing to help the community of HD families.  HD has been called the cruelest disease known to man. “We have the opportunity, through a value added ag product, to be able to impact lives.” said Susan Holler, VP of GlycoScience Research. “The Research Park has been pivotal for networking and providing a location for our start up lab. It has truly been a Godsend. We’re very appreciative for the support that enables entrepreneurs to start and grow businesses here.”

Continued growth for GlycoScience Research will include expansion of lab facilities, pharmaceutical grade manufacturing facilities and possibly a pharmaceutical company. Additionally, expansion and revitalization of the sheep industry in SD and nationwide to provide the lambs that are the source of the value added product will have significant economic impact for producers as they make a difference for others.

“Providing a place for innovative technologies to grow and succeed is what the BIC is all about,” said Melissa Werner, director of operations at the Brookings Innovation Center. “Larry and Susan have been following their dream for over 20 years to bring their product to commercialization and improve the quality of life for patients suffering from neurological diseases.”

Print Friendly, PDF & Email